BIOMAT Database Logo BIOMAT Database Logo

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. 1998

A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. fmedamt@chulkn.chula.ac.th

This study evaluated Epstein-Barr virus (EBV) DNA in sera of 42 patients with nasopharyngeal carcinoma (NPC) and 82 healthy individuals who had been infected previously with EBV. Thirteen of 42 NPC samples were positive for EBV DNA in their sera, whereas all 82 normal controls were negative. In addition, EBV typing between primary tumors and sera showed identical results, suggesting that serum EBV DNA represented tumor DNA. To evaluate the importance of the serum NPC DNA, clinical data and tumor phenotypes including age, sex, WHO type, EBV type, stage, tumor invasion, metastasis, and apoptosis were correlated with serum EBV DNA, and only apoptosis was found statistically significant. In conclusion, EBV DNA was detectable in the serum of some patients with NPC, represented tumor DNA, and might have clinical implications in the future.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious

Related Publications

A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.
August 2017, Cancer science,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
[Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
September 2000, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Epstein-Barr virus DNA measured in nasopharyngeal brushings in patients with nasopharyngeal carcinoma: pilot study.
October 2004, The Journal of otolaryngology,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
January 2001, Indian journal of cancer,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma.
October 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
June 2004, The New England journal of medicine,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
March 1978, British journal of cancer,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy.
September 2011, Oral oncology,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
January 2017, International journal of cancer,
A Mutirangura, and W Pornthanakasem, and A Theamboonlers, and V Sriuranpong, and P Lertsanguansinchi, and S Yenrudi, and N Voravud, and P Supiyaphun, and Y Poovorawan
Epstein-Barr Viral Antigens Used in the Diagnosis of Nasopharyngeal Carcinoma.
January 1996, Journal of biomedical science,
Copied contents to your clipboard!